News From Around the Web
> A study published this month in the Journal of Perinatology found that a telemedicine collaboration improved perinatal regionalization and lowered statewide infant mortality in Arkansas. The research used obstetrical and neonatal interventions through telemedicine consults, education and census rounds with nine hospitals from July 1, 2009, to March 31, 2010. Study
> Care Innovations telehealth tool, Care RCM, was recently cleared by the U.S. Food and Drug Administration, according to a company announcement. Connect RCM is the cloud-based patient application of the Care Innovations Guide platform, an established remote care management solution that has been deployed in 42 states. Announcement
Provider News
> The Institute of Medicine has declared a cancer care crisis in the United States, due to a growing demand for cancer care, a shrinking workforce, rising healthcare costs and the increasing complexity of treatment, according to a new report. An IOM-convened committee of experts found U.S. cancer care is not patient-centered, many patients do not receive palliative care and decisions about care are not always based on the latest scientific evidence. Article
> Hospitals should carefully review advertisements to make sure they don't cross the line between puffery and false advertising, according to a brief in Lexology. Kathleen Rheintgen, senior counsel with Husch Blackwell, wrote there is a fine line between puffery and false advertising "if these ads cause patients or their families to expect more than what is or even can be offered." Article
Mobile Healthcare News
> The U.S. Food and Drug Administration is offering regulatory input to teams competing in the $10 million Qualcomm Tricorder XPRIZE, a global competition to develop a consumer-friendly device capable of diagnosing and interpreting a set of 15 health conditions and capturing key vital signs. The FDA's role was announced by XPRIZE, the organizer of the competition. Article
And Finally... "The Jungle Book" comes to life. Article